(The new advisory panel includes several members with ties to the peptides industry, raising concerns about its impartiality.) After the first day of deliberation, the panel voted in favor of easing restrictions on two popular peptidesBPC-157 and KPVdespite the fact that other FDA scientists have publicly raised concerns about the lack of evidence for these compounds
Combination studies: A 2015 study found that GHK-Cu combined with other hair-active peptides outperformed placebo on trichoscopic measures of follicle density and diameter
Mroz, P
Absence of head-to-head human comparison There is no published human study that directly compares injectable GHK-Cu against topical GHK-Cu for any skin endpoint
However, to date, the majority of studies have been performed on small rodent models and the efficacy of BPC 157 is yet to be confirmed in humans
Furthermore, evidence in the rats has so far shown the recovery of the various muscle disabilities deriving from a multitude of different causes, peripheral and central, given that muscle weakness was part of the primary disturbance that was also attenuated
